Medsolve Dynamics

Two clocks run underneath every capital decision made this fall. One of them can still move. The other one locks. From "Protecting Program Margin, Part Two," AMAC Summer Seminar 2026. Yoel Bakas spent thirteen years at Varian, then ran global sales at Mevion, strategic operations at ViewRay and the oncology national accounts at GE HealthCare. He founded Medsolve Dynamics to work the other side of those deals. medsolvedynamics.com · [email protected]

Acceptance proves the machine is what was bought. It says nothing about the volume the purchase was approved on. Yoel Bakas of Medsolve Dynamics, twenty years on the vendor side of these agreements, on which assumptions a capital purchase puts somebody on the hook for and which ones belong to the program alone.

medsolvedynamics.com · [email protected]

Before asking for another treatment machine, establish what limits the ones already in service. Yoel Bakas of Medsolve Dynamics explains why a capital review needs staffed hours and treatment mix beside the activity figures, and how those conditions affect a comparison with the vendor's proposal.

medsolvedynamics.com · [email protected]

Twenty years on the vendor side, and an honest answer about which machine to buy would still have been his machine. Yoel Bakas on where a vendor's physicist sits on that one question, and only that one, and what to write down under each physics arrangement before the next capital decision. Full issue: oncologyoperator.com. Yoel Bakas ran national accounts at GE HealthCare, strategic operations at ViewRay and global sales at Mevion. He founded Medsolve Dynamics to work the other side of those deals. medsolvedynamics.com · [email protected]

One flat service rate on a one-year-old linear accelerator and a twenty-year-old one means the LINAC service contract price is not built from parts, labor, travel or downtime history. Yoel Bakas on the number to check before a radiation oncology service agreement renewal or a service contract negotiation. Clip from the AMAC Summer Seminar 2026. Yoel Bakas ran national accounts at GE HealthCare, strategic operations at ViewRay and global sales at Mevion. He founded Medsolve Dynamics to work the other side of those deals. medsolvedynamics.com · [email protected] · oncologyoperator.com

Yoel Bakas on why a competing bid earns its keep even when everyone knows which vendor wins, and what one question did for a vault budget. From Yoel Bakas's AMAC Summer Seminar 2026 session; this cut is an episode of the Medsolve Dynamics podcast. Yoel Bakas ran national accounts at GE HealthCare, strategic operations at ViewRay and global sales at Mevion. He founded Medsolve Dynamics to work the other side of those deals. medsolvedynamics.com · [email protected]

Every hospital-based cancer program pays its own institution for space, lab and IT, and almost none can show how the figure was built. Yoel Bakas on why the largest number in a capital file is often the one nobody negotiates. From Medsolve Dynamics. medsolvedynamics.com | [email protected]

Every service agreement has one clause that grows on its own, and it is almost never the clause that gets negotiated. Yoel Bakas on what a five percent annual step actually costs across a five year term, why the arithmetic surprises people who have signed dozens of these, and where the money goes when nobody owns the renewal date. Recorded at the AMAC Summer Seminar 2026. From Medsolve Dynamics. medsolvedynamics.com | [email protected]

The radiopharmaceutical supply chain consolidated on paper on August 3, 2026, when Curium and Lantheus signed a definitive merger agreement. Yoel Bakas on why the period between signing and closing — an outside date of May 2, 2027, with extensions capped at November 30 — is the only window in which a supplier has a structural reason to give you terms, and what to ask for while it is open. From Medsolve Dynamics.

[email protected] | medsolvedynamics.com

A radiation oncology capital price that has not moved in twenty years.

Onboard imaging, arc delivery, the next iteration of arc delivery, a couch upgrade — all half a million dollars. The same couch is $250,000 on the older platform and half a million on the new one. Yoel Bakas spent two decades on the vendor side handing programs that number, and explains what it actually is: an anchor set to shape your budget before you have built the case for the purchase.

Covered: how anchor pricing differs from cost-based pricing, why the number is self-reinforcing, what belongs in a one-page business case for a capital add-on, and how to arrive at a vendor meeting with your own number instead of theirs.

Medsolve Dynamics — capital strategy, financial strategy, revenue and margin growth, and AI reality checks for oncology programs.

[email protected] | medsolvedynamics.com